XML 19 R6.htm IDEA: XBRL DOCUMENT v3.25.0.1
Consolidated Statements of Cash Flows - USD ($)
$ in Millions
12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Cash flows from operating activities:      
Net income $ 313 $ 228 $ 233
Adjustments to reconcile net income to net cash provided by operating activities:      
Depreciation and amortization 496 458 417
Deferred income taxes 23 8 6
Public Utilities, Allowance for Funds Used During Construction, Capitalized Cost of Equity (23) (19) (14)
Pension and other postretirement benefits 6 5 13
Decoupling mechanism deferrals, net of amortization 40 (11) (11)
Share-based Payment Arrangement, Noncash Expense 24 17 15
Increase (Decrease) in Other Regulatory Assets (126) 20 (46)
Increase (Decrease) in Regulatory Liabilities (20) 24 5
Other Operating Activities, Cash Flow Statement 112 24 0
Other non-cash income and expenses, net 57 40 40
Changes in working capital:      
Decrease (increase) in receivables and unbilled revenues (66) (29) (66)
(Increase) in margin deposits (33) 24 (80)
(Decrease) increase in payables and accrued liabilities 47 (166) 157
Increase (Decrease) in Contract with Customer, Asset 0 (135) 82
Other working capital items, net (12) (20) (22)
Contribution to non-qualified employee benefit trust (10) (7) (9)
Asset Retirement Obligation, Cash Paid to Settle (16) (25) (27)
Other, net (34) (16) (19)
Net cash provided by operating activities 778 420 674
Cash flows from investing activities:      
Capital expenditures (1,268) (1,358) (766)
Purchases of nuclear decommissioning trust securities (8) (1) (3)
Sales of nuclear decommissioning trust securities 2 1 3
Other, net (23) 0 8
Net cash used in investing activities (1,297) (1,358) (758)
Cash flows from financing activities:      
Proceeds from issuance of long-term debt 670 600 360
Payments on long-term debt (130) (260) 0
Proceeds from Issuance or Sale of Equity 346 485 0
Proceeds from (Repayments of) Commercial Paper (146)    
Proceeds from Issuance of Commercial Paper   146 0
Proceeds from Other Debt 0 0 25
Dividends paid (200) (179) (158)
Payments for Repurchase of Common Stock 0 0 (18)
Other (14) (14) (12)
Net cash used in financing activities 526 778 197
(Decrease) increase in cash and cash equivalents 7 (160) 113
Cash and cash equivalents, beginning of year 5 165 52
Cash and cash equivalents, end of year 12 5 165
Supplemental disclosures of cash flow information:      
Cash paid for interest, net of amounts capitalized 174 136 128
Proceeds from Income Tax Refunds (90)    
Cash paid for income taxes   12 37
Non-cash investing and financing activities:      
Accrued capital additions 184 212 111
Accrued dividends payable $ 57 $ 51 $ 42